These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24507115)

  • 1. [Application of immunohistochemistry in diagnosis of ALK-positive non-small cell lung cancer].
    Du X; Zhou XY; Lü N; Li XH; Ying JM; Yang F; Li Y; Sun Y; Zhao M; Zhou LX
    Zhonghua Bing Li Xue Za Zhi; 2013 Dec; 42(12):858-60. PubMed ID: 24507115
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of reverse transcription-polymerase chain reaction, immunohistochemistry, and fluorescence in situ hybridization methodologies for detection of echinoderm microtubule-associated proteinlike 4-anaplastic lymphoma kinase fusion-positive non-small cell lung carcinoma: implications for optimal clinical testing.
    Wallander ML; Geiersbach KB; Tripp SR; Layfield LJ
    Arch Pathol Lab Med; 2012 Jul; 136(7):796-803. PubMed ID: 22742552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Application of fluorescence in-situ hybridization in diagnosis of ALK-positive non-small cell lung cancer].
    Zhou XY
    Zhonghua Bing Li Xue Za Zhi; 2013 Dec; 42(12):854-6. PubMed ID: 24507113
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: correlation with fluorescence in situ hybridization.
    Paik JH; Choe G; Kim H; Choe JY; Lee HJ; Lee CT; Lee JS; Jheon S; Chung JH
    J Thorac Oncol; 2011 Mar; 6(3):466-72. PubMed ID: 21258247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Consensus on dignosis for ALK positive non-small cell lung cancer in China, the 2013 version].
    Zhang XC; Lu S; Zhang L; Wang CL; Cheng Y; Li GD; Mok T; Huang C; Liu XQ; Wang J; Wang MZ; Zhang YP; Zhou JY; Zhou XY; Lin DM; Yang JJ; Li H; Chen HQ; Zhong WZ; Wu YL
    Zhonghua Bing Li Xue Za Zhi; 2013 Jun; 42(6):402-6. PubMed ID: 24060077
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening for ALK in non-small cell lung carcinomas: 5A4 and D5F3 antibodies perform equally well, but combined use with FISH is recommended.
    Savic S; Diebold J; Zimmermann AK; Jochum W; Baschiera B; Grieshaber S; Tornillo L; Bisig B; Kerr K; Bubendorf L
    Lung Cancer; 2015 Aug; 89(2):104-9. PubMed ID: 26056079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of polymerase chain reaction technique in diagnosis for ALK-positive non-small cell lung cancer].
    Zhang J
    Zhonghua Bing Li Xue Za Zhi; 2013 Dec; 42(12):856-8. PubMed ID: 24507114
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of ALK expression in non-small-cell lung cancer with ALK gene rearrangements--comparison of multiple immunohistochemical methods.
    Zwaenepoel K; Van Dongen A; Lambin S; Weyn C; Pauwels P
    Histopathology; 2014 Oct; 65(4):539-48. PubMed ID: 24621075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of rearrangements and transcriptional up-regulation of ALK in FFPE lung cancer specimens using a novel, sensitive, quantitative reverse transcription polymerase chain reaction assay.
    Gruber K; Horn H; Kalla J; Fritz P; Rosenwald A; Kohlhäufl M; Friedel G; Schwab M; Ott G; Kalla C
    J Thorac Oncol; 2014 Mar; 9(3):307-15. PubMed ID: 24495999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of IHC and FISH for ALK gene rearrangement in non-small cell lung carcinoma: IHC score algorithm for FISH.
    Yi ES; Boland JM; Maleszewski JJ; Roden AC; Oliveira AM; Aubry MC; Erickson-Johnson MR; Caron BL; Li Y; Tang H; Stoddard S; Wampfler J; Kulig K; Yang P
    J Thorac Oncol; 2011 Mar; 6(3):459-65. PubMed ID: 21278610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of ALK gene rearrangement in non-small cell lung cancer: a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization with correlation of ALK protein expression.
    Kim H; Yoo SB; Choe JY; Paik JH; Xu X; Nitta H; Zhang W; Grogan TM; Lee CT; Jheon S; Chung JH
    J Thorac Oncol; 2011 Aug; 6(8):1359-66. PubMed ID: 21587085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of ALK rearrangement by immunohistochemistry in lung adenocarcinoma and the identification of a novel EML4-ALK variant.
    To KF; Tong JH; Yeung KS; Lung RW; Law PP; Chau SL; Kang W; Tong CY; Chow C; Chan AW; Leung LK; Mok TS
    J Thorac Oncol; 2013 Jul; 8(7):883-91. PubMed ID: 23625156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALK status testing in non-small-cell lung carcinoma by FISH on ThinPrep slides with cytology material.
    Minca EC; Lanigan CP; Reynolds JP; Wang Z; Ma PC; Cicenia J; Almeida FA; Pennell NA; Tubbs RR
    J Thorac Oncol; 2014 Apr; 9(4):464-8. PubMed ID: 24736067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An activating ALK gene mutation in ALK IHC-positive/FISH-negative nonsmall-cell lung cancer.
    Togashi Y; Mizuuchi H; Kobayashi Y; Hayashi H; Terashima M; Sakai K; Banno E; Mizukami T; Nakamura Y; de Velasco MA; Fujita Y; Tomida S; Mitsudomi T; Nishio K
    Ann Oncol; 2015 Aug; 26(8):1800-1. PubMed ID: 26002608
    [No Abstract]   [Full Text] [Related]  

  • 15. Exon scanning by reverse transcriptase-polymerase chain reaction for detection of known and novel EML4-ALK fusion variants in non-small cell lung cancer.
    Sanders HR; Li HR; Bruey JM; Scheerle JA; Meloni-Ehrig AM; Kelly JC; Novick C; Albitar M
    Cancer Genet; 2011 Jan; 204(1):45-52. PubMed ID: 21356191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of methods in the detection of ALK and ROS1 rearrangements in lung cancer.
    Rogers TM; Russell PA; Wright G; Wainer Z; Pang JM; Henricksen LA; Singh S; Stanislaw S; Grille J; Roberts E; Solomon B; Fox SB
    J Thorac Oncol; 2015 Apr; 10(4):611-8. PubMed ID: 25789833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIP1-ALK, a novel fusion protein identified in lung adenocarcinoma.
    Hong M; Kim RN; Song JY; Choi SJ; Oh E; Lira ME; Mao M; Takeuchi K; Han J; Kim J; Choi YL
    J Thorac Oncol; 2014 Mar; 9(3):419-22. PubMed ID: 24518094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALK status testing in non-small cell lung carcinoma: correlation between ultrasensitive IHC and FISH.
    Minca EC; Portier BP; Wang Z; Lanigan C; Farver CF; Feng Y; Ma PC; Arrossi VA; Pennell NA; Tubbs RR
    J Mol Diagn; 2013 May; 15(3):341-6. PubMed ID: 23499337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are anaplastic lymphoma kinase gene rearrangements in non-small cell lung cancer prognostic, predictive, or both?
    Solomon B; Shaw AT
    J Thorac Oncol; 2012 Jan; 7(1):5-7. PubMed ID: 22173659
    [No Abstract]   [Full Text] [Related]  

  • 20. Parallel screening for ALK, MET and ROS1 alterations in non-small cell lung cancer with implications for daily routine testing.
    Jurmeister P; Lenze D; Berg E; Mende S; Schäper F; Kellner U; Herbst H; Sers C; Budczies J; Dietel M; Hummel M; von Laffert M
    Lung Cancer; 2015 Feb; 87(2):122-9. PubMed ID: 25534130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.